ZNF33A promotes tumor progression and BET inhibitor resistance in triple-negative breast cancer. Wang X, Wei X, Cao Y, Xing P, et al. Am J Pathol 2022 Jul 14. pii: S0002-9440(22)00199.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Wei X, Cao Y, Xing P, et al. ZNF33A promotes tumor progression and BET inhibitor resistance in triple-negative breast cancer. Am J Pathol 2022 Jul 14. pii: S0002-9440(22)00199.
PMID: 35843263